Recall Z-0973-2014— Medtronic Navigation, Inc.

Name: FDA recall Z-0973-2014
Creator: U.S. Food and Drug Administration
Published: 2013-07-25

Class II · Terminated

Class II FDA medical device recall by Medtronic Navigation, Inc., initiated 2013-07-25, terminated 2019-04-17. It names one FDA 510(k) clearance: K092564. Product: Medtronic O-arm Imaging System Mobile X-ray system. Model No. BI-700-00027 and BI-700-00028 The 0-arm Imaging System is a mobile x-ray system designed for 2D fluoroscopic and 3D imaging and is intended to be used where a physician benefits from 2D and 3D information of anatomic structures and objects with high x-ray attenuation such as bony anatomy and metallic objects. The 0-ann Imaging System is compatible with certain Image Guided Surgery Systems.. Reason: Review of on-system electronic product labeling and Instructions for comply with applicable Use in response to a customer inquiry uncovered gaps in compliance FDA standards with the requirements for information to be provided to users in 21CFR 1020.30(h).

Recalling firm: Medtronic Navigation, Inc.
Classification: Class II
Status: Terminated
Initiated: 2013-07-25
Terminated: 2019-04-17
Firm location: Littleton, MA, United States

510(k) clearances named in this recall

1 on FDA's record

K092564 — O-ARM IMAGING SYSTEMMedtronic Navigation, Inc. (Littleton)·cleared 2010-06-17

K-numbers as listed on FDA's Recall Enterprise System record for this event (openFDA device/recall k_numbers). The recall may also cover devices cleared under other submissions not named here.

Product description

Medtronic O-arm Imaging System Mobile X-ray system. Model No. BI-700-00027 and BI-700-00028 The 0-arm Imaging System is a mobile x-ray system designed for 2D fluoroscopic and 3D imaging and is intended to be used where a physician benefits from 2D and 3D information of anatomic structures and objects with high x-ray attenuation such as bony anatomy and metallic objects. The 0-ann Imaging System is compatible with certain Image Guided Surgery Systems.

Reason for recall

Review of on-system electronic product labeling and Instructions for comply with applicable Use in response to a customer inquiry uncovered gaps in compliance FDA standards with the requirements for information to be provided to users in 21CFR 1020.30(h)

Data sourced from openFDA. This site is unofficial and independent of the FDA.